Does Dr. AYSHA AGARWAL have financial conflicts of interest?

Dr. AYSHA AGARWAL (MD) has received a total of $1,735 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,735 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. AYSHA AGARWAL?

According to CMS Open Payments data, Dr. AYSHA AGARWAL received funding from PULMONX CORPORATION ($741), OLYMPUS AMERICA ($305), and UNITED THERAPEUTICS CORPORATION ($161).

Does Dr. AYSHA AGARWAL receive research grants or speaking fees?

Dr. AYSHA AGARWAL has received $1,735 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. AYSHA AGARWAL

MDReal-Time Hydrated

Specialty: Internal Medicine, Critical Care Medicine

Practice Location: PHOENIX, AZ 85020

NPI Number: 1033564026

LIFETIME INDUSTRY VALUE

$1,735

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AGARWAL is a verified Internal Medicine, Critical Care Medicine practitioner based in PHOENIX, AZ.

Between 2021 and 2025, Dr. AGARWAL had an overall industry promotional and research financial footprint of $1,735 as recorded in the federal CMS Open Payments database.

$1,735 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGARWAL's primary funding source is PULMONX CORPORATION, which accounts for $741 (representing 42.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

PULMONX CORPORATION

Rank 1

$741

42.7%

OLYMPUS AMERICA

Rank 2

$305

17.6%

UNITED THERAPEUTICS CORPORATION

Rank 3

$161

9.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.